Clinical Features and Classification

  • Dirk Schadendorf
  • Corinna Kochs
  • Elisabeth Livingstone


Clark et al were the first to divide melanoma into subtypes depending on clinical and histologic features, criteria that were later used by other researchers. The majority of all melanomas fall into the following four subtypes (the World Health Organization [WHO] classification of melanoma).


Cutaneous Melanoma Mitotic Rate Primary Melanoma Tumor Thickness BRAF Inhibitor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Clark WH Jr, From L, Bernardino EA, Mihm MC. The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res. 1969;29:705-727.Google Scholar
  2. 2.
    Smoller BR, Histologic criteria for diagnosing primary cutaneous malignant melanoma. Mod Pathol. 2006;19(suppl 2):S34-S40.Google Scholar
  3. 3.
    Kaatsch P, Spix C, Katalinic A, Hentschel S. Malignes melanom der haut. In: Krebs in Deutschland 2007/2008. Berlin, Germany: Robert Koch-Institut; 2012:60-63.Google Scholar
  4. 4.
    Bradford PT, Goldstein AM, McMaster ML, Tucker MA. Acral lentiginous melanoma: incidence and survival patterns in the United States, 1986-2005. Arch Dermatol. 2009;145:427-434.Google Scholar
  5. 5.
    Glud M, Gniadecki R. MicroRNAs in the pathogenesis of malignant melanoma. J Eur Acad Dermatol Venereol. 2013;27:142-150.Google Scholar
  6. 6.
    Pollack LA, Li J, Berkowitz Z, et al. Melanoma survival in the United States, 1992 to 2005. J Am Acad Dermatol. 2011;65(5 suppl 1):S78-S86.Google Scholar
  7. 7.
    World Health Organization classification of tumours. International Agency for Research in Cancer. Accessed June 20, 2013.
  8. 8.
    Chen LL, Jaimes N, Barker CA, Busam KJ, Marghoob AA. Desmoplastic melanoma: a review. J Am Acad Dermatol. 2013;68:825-833.Google Scholar
  9. 9.
    Curtin JA, Fridlyand J, Kageshita T, et al. Distinct sets of genetic alterations in melanoma. N Engl J Med. 2005;353:2135-2147.Google Scholar
  10. 10.
    Vidwans SJ, Flaherty KT, Fisher DE, Tenenbaum JM, Travers MD, Shrager J. A melanoma molecular disease model. PLoS One. 2011;6:e18257.Google Scholar
  11. 11.
    Curtin JA, Busam K, Pinkel D, Bastian BC. Somatic activation of KIT in distinct subtypes of melanoma. J Clin Oncol. 2006;24:4340-4346.Google Scholar
  12. 12.
    Balch CM, Gershenwald JE, Soong S-J, at al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27:6199-6206.Google Scholar
  13. 13.
    Balch CM, Buzaid AC, Soong S-J, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol. 2001;19:3635-3648.Google Scholar
  14. 14.
    Individualized melanoma patient outcome prediction tools. American Joint Committee on Cancer. Accessed June 20, 2013.
  15. 15.
    Meier F, Will S, Ellwanger U, et al. Metastatic pathways and time courses in the orderly progression of cutaneous melanoma. Br J Dermatol. 2002;147:62-70.Google Scholar
  16. 16.
    Gamel JW, George SL, Edwards MJ, Seigler HF. The long-term clinical course of patients with cutaneous melanoma. Cancer. 2002;95:1286-1293.Google Scholar
  17. 17.
    Liu W, Dowling JP, Murray WK, et al. Rate of growth in melanomas: characteristics and associations of rapidly growing melanomas. Arch Dermatol. 2006;142:1551-1558.Google Scholar
  18. 18.
    Soong S-J, Harrison RA, McCarthy WH, Urist MM, Balch CM. Factors affecting survival following local, regional, or distant recurrence from localized melanoma. J Surg Oncol. 1998;67:228-233.Google Scholar
  19. 19.
    Hofmann U, Szedlak M, Rittgen W, Jung EG, Schadendorf D. Primary staging and follow-up in melanoma patients – monocenter evaluation of methods, costs and patient survival. Br J Cancer. 2002;87:151-157.Google Scholar
  20. 20.
    Dicker TJ, Kavanagh GM, Herd RM, et al; Scottish Melanoma Group. A rational approach to melanoma follow-up in patients with primary cutaneous melanoma. Br J Dermatol. 1999;140:249-254.Google Scholar
  21. 21.
    Crowley NJ, Seigler HF. Late recurrence of malignant melanoma. Analysis of 168 patients. Ann Surg. 1990;212:173-177.Google Scholar

Copyright information

© Springer Healthcare 2013

Authors and Affiliations

  • Dirk Schadendorf
    • 1
  • Corinna Kochs
    • 2
  • Elisabeth Livingstone
    • 2
  1. 1.Dermatology, Venereology and AllergologyUniversity Hospital EssenEssenGermany
  2. 2.Department for DermatologyUniversity Hospital EssenEssenGermany

Personalised recommendations